These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32106601)

  • 1. Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients.
    Chaudhry SR; Kahlert UD; Kinfe TM; Lamprecht A; Niemelä M; Hänggi D; Muhammad S
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 3. Temporal profile of serum mitochondrial DNA (mtDNA) in patients with aneurysmal subarachnoid hemorrhage (aSAH).
    Chaudhry SR; Frede S; Seifert G; Kinfe TM; Niemelä M; Lamprecht A; Muhammad S
    Mitochondrion; 2019 Jul; 47():218-226. PubMed ID: 30529453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).
    Chaudhry SR; Kinfe TM; Lamprecht A; Niemelä M; Dobreva G; Hänggi D; Muhammad S
    Cytokine; 2020 Sep; 133():155142. PubMed ID: 32485621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma D-dimer may predict poor functional outcomes through systemic complications after aneurysmal subarachnoid hemorrhage.
    Fukuda H; Lo B; Yamamoto Y; Handa A; Yamamoto Y; Kurosaki Y; Yamagata S
    J Neurosurg; 2017 Aug; 127(2):284-290. PubMed ID: 27518526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Dynamics of Interleukin-6 in Cerebrospinal Fluid after Aneurysmal Subarachnoid Hemorrhage.
    Ďuriš K; Neuman E; Vybíhal V; Juráň V; Gottwaldová J; Kýr M; Vašků A; Smrčka M
    J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):145-151. PubMed ID: 28869993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage.
    Fujiki Y; Matano F; Mizunari T; Murai Y; Tateyama K; Koketsu K; Kubota A; Kobayashi S; Yokota H; Morita A
    J Neurosurg; 2018 Oct; 129(4):870-875. PubMed ID: 29148905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Woodworth GF; Ali M; Than KD; Tamargo RJ; Clatterbuck RE
    J Neurosurg; 2007 Dec; 107(6):1080-5. PubMed ID: 18077943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Initial Systemic Inflammatory Response After Aneurysmal Subarachnoid Hemorrhage.
    Zhong W; Zhang Z; Zhao P; Shen J; Li X; Wang D; Li G; Su W
    Turk Neurosurg; 2017; 27(3):346-352. PubMed ID: 27593784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic High-Mobility Group Box-1: A Novel Predictive Biomarker for Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Chaudhry SR; Güresir A; Stoffel-Wagner B; Fimmers R; Kinfe TM; Dietrich D; Lamprecht A; Vatter H; Güresir E; Muhammad S
    Crit Care Med; 2018 Nov; 46(11):e1023-e1028. PubMed ID: 30028365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
    Galea J; Ogungbenro K; Hulme S; Patel H; Scarth S; Hoadley M; Illingworth K; McMahon CJ; Tzerakis N; King AT; Vail A; Hopkins SJ; Rothwell N; Tyrrell P
    J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Outcome in Subarachnoid Hemorrhage (SAH) Utilizing the Full Outline of UnResponsiveness (FOUR) Score.
    Zeiler FA; Lo BWY; Akoth E; Silvaggio J; Kaufmann AM; Teitelbaum J; West M
    Neurocrit Care; 2017 Dec; 27(3):381-391. PubMed ID: 28382509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage - Serum D-dimer and C-reactive Protein as Early Markers.
    Hurth H; Birkenhauer U; Steiner J; Schlak D; Hennersdorf F; Ebner FH
    J Stroke Cerebrovasc Dis; 2020 Mar; 29(3):104558. PubMed ID: 31889655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Schebesch KM; Brawanski A; Bele S; Schödel P; Herbst A; Bründl E; Kagerbauer SM; Martin J; Lohmeier A; Stoerr EM; Proescholdt M
    Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage.
    Mack WJ; Mocco J; Hoh DJ; Huang J; Choudhri TF; Kreiter KT; Lozier A; Opperman M; Poisik A; Yorgason J; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Jan; 96(1):71-5. PubMed ID: 11794607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Glucose and Potassium Ratio as Risk Factors for Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.
    Matano F; Fujiki Y; Mizunari T; Koketsu K; Tamaki T; Murai Y; Yokota H; Morita A
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1951-1957. PubMed ID: 31060790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.
    Fischer M; Dietmann A; Beer R; Broessner G; Helbok R; Pfausler B; Schmutzhard E; Lackner P
    PLoS One; 2013; 8(3):e59952. PubMed ID: 23555845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.